Innovations, regulations, societal and political support and energy demand constantly develop, and often in unpredictable ways.
New creative approaches are needed to manage emerging biotechnology innovations, regulations, and payor environments to enhance product pipeline productivity, valuation, and risk management.
As such, new creative approaches are needed to manage emerging biotechnology innovations, regulations, and payor environments to enhance product pipeline productivity, valuation, and risk management, all of which are critical to future industry development and national competitiveness (Beach, 2011; Ford et al. 2008; Lindgren and Packendorff, 2011; Roy, 2012).
Governance mechanism that operates on the demand side in stimulating innovation: government regulations and subsidies affecting the sale of goods by making their uptake more attractive for the users.
As Harvard Business School management guru Michael Porter has demonstrated, US firms have shown again and again that they can and will respond with hard work and innovation when regulations offer them flexibility and a fair playing field.
While government is bringing regulation to innovators, there's an opportunity to bring innovation to regulation.
Speaking more generally, he suggested that governments need to "find the balance" between regulation and innovation, because "the regulations tend to benefit the current incumbents".
However, innovation and regulation have not always been easily compatible.
Ms. Browner said that innovation and regulation were not contradictory policies, but complementary means to an end.
It is the latest example of the tension between technological innovation and regulation, which move at very different speeds.
